A Guide to the Economics of Hepatitis C Virus Cure in 2017

Infectious Disease Clinics of North America
Benjamin P Linas, Shayla Nolen

Abstract

This commentary reviews the core principals of cost-effectiveness and applies them to the rapidly evolving context of hepatitis C virus treatment in the United States. The article provides a foundation of evidence that hepatitis C virus treatment provides good economic value, even though it is expensive, and even when treating people who inject drugs who are at high risk for hepatitis C virus reinfection. The price of medications has decreased, but the high price continues to limit access to care. This wedge between cost effectiveness and affordability stands front and center as one of the leading obstacles to elimination.

Citations

Mar 29, 2020·Expert Review of Gastroenterology & Hepatology·Omar Massoud
Mar 9, 2021·Hepatology Communications·Nancy Yang, Andrew Muir

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Related Papers

The International Journal on Drug Policy
Jason GrebelyInternational Network for Hepatitis in Substance Users
The Lancet Infectious Diseases
Peter J White, Ibrahim Abubakar
Journal of Gastroenterology and Hepatology
Natasha K MartinMatthew Hickman
The International Journal on Drug Policy
Jason GrebelyInternational Network for Hepatitis in Substance Users
JAMA Internal Medicine
Robert Steinbrook, Rita F Redberg
© 2022 Meta ULC. All rights reserved